Immediate Impact
34 standout
Citing Papers
H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
2023 Standout
Works of A. Chalmers being referenced
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up
2019
High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Chalmers | 164 | 90 | 90 | 114 | 28 | 290 | |
| Hun-Mo Ryoo | 102 | 107 | 105 | 95 | 30 | 291 | |
| Yuliya Linhares | 91 | 66 | 75 | 92 | 27 | 273 | |
| Praveen Ramakrishnan Geethakumari | 170 | 64 | 48 | 41 | 45 | 283 | |
| Wolfgang Langer | 123 | 99 | 74 | 69 | 21 | 308 | |
| A Pedrazzini | 135 | 68 | 44 | 66 | 23 | 243 | |
| Clara Lam | 121 | 50 | 40 | 51 | 19 | 322 | |
| Paul M. Diderichsen | 113 | 60 | 99 | 89 | 36 | 327 | |
| Bita Fakhri | 124 | 22 | 69 | 110 | 37 | 254 | |
| Klaus Hoeffken | 93 | 53 | 42 | 56 | 22 | 249 | |
| Mahran Shoukier | 90 | 29 | 77 | 114 | 22 | 236 |
All Works
Login with ORCID to disown or claim papers
Loading papers...